These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30043109)

  • 1. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.
    Ruiz B; Aguirre U; Estany-Gestal A; Rodella L; Ruiz P; Figueiras A; Carvajal A; Ibáñez L; Conforti A; de Pancorbo MM; Vidal X; Martin LH; Aguirre C
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1503-1511. PubMed ID: 30043109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications.
    Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy.
    Jensen BES; Hansen JM; Larsen KS; Junker AB; Lassen JF; Jensen SE; Schaffalitzky de Muckadell OB
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1118-1125. PubMed ID: 28678044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
    Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.
    Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
    Gastroenterology; 2016 Dec; 151(6):1105-1112.e10. PubMed ID: 27639805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
    Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan.
    Miyamoto M; Haruma K; Okamoto T; Higashi Y; Hidaka T; Manabe N
    J Gastroenterol Hepatol; 2012 Feb; 27(2):372-7. PubMed ID: 21793917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
    Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
    United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy.
    Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
    J Gastroenterol Hepatol; 2014 Oct; 29(10):1786-93. PubMed ID: 24720424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy.
    Lin KJ; Hernández-Díaz S; García Rodríguez LA
    Gastroenterology; 2011 Jul; 141(1):71-9. PubMed ID: 21458456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study.
    Nagata N; Niikura R; Yamada A; Sakurai T; Shimbo T; Kobayashi Y; Okamoto M; Mitsuno Y; Ogura K; Hirata Y; Fujimoto K; Akiyama J; Uemura N; Koike K
    PLoS One; 2016; 11(3):e0151332. PubMed ID: 26978517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].
    Zhang ZF; Sha WH; Tan GY; Wang QY
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):445-50. PubMed ID: 27256606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.
    Lanas A; García-Rodríguez LA; Arroyo MT; Gomollón F; Feu F; González-Pérez A; Zapata E; Bástida G; Rodrigo L; Santolaria S; Güell M; de Argila CM; Quintero E; Borda F; Piqué JM;
    Gut; 2006 Dec; 55(12):1731-8. PubMed ID: 16687434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.
    Lanas Á; Carrera-Lasfuentes P; Arguedas Y; García S; Bujanda L; Calvet X; Ponce J; Perez-Aísa Á; Castro M; Muñoz M; Sostres C; García-Rodríguez LA
    Clin Gastroenterol Hepatol; 2015 May; 13(5):906-12.e2. PubMed ID: 25460554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 16. High prevalence of ulcer bleeding risk factors in dual antiplatelet-treated patients after percutaneous coronary intervention.
    Jensen BE; Hansen JM; Junker AB; Lassen JF; Jensen SE; Schaffalitzky de Muckadell OB
    Dan Med J; 2015 Jun; 62(6):. PubMed ID: 26036886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
    Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy.
    Yang S; Shi L
    Inflammopharmacology; 2024 Jun; 32(3):1999-2006. PubMed ID: 38642222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin.
    Nagata N; Niikura R; Aoki T; Sakurai T; Moriyasu S; Shimbo T; Sekine K; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
    J Gastroenterol; 2015 Nov; 50(11):1079-86. PubMed ID: 25700638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.
    Bakhriansyah M; Souverein PC; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1141-1148. PubMed ID: 28370857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.